Insider trading

Period: 120 months Stock: ARDX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

346 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

346 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

346 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

346 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
346 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
346 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

346 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
20 Nov 2023
Felsch Robert Ora See Remarks
Sold at will
$4.55K 1,044 at 4.36
0.9%
Not planned
20 Nov 2023
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$4.07K 932 at 4.36
0.8%
Not planned
15 Nov 2023
Williams Laura A Chief Medical Officer
Sold at will
$100.00K 25,000 at 4.00
8.6%
Not planned
10 Oct 2023
Rosenbaum David P. Chief Development Officer
Sold on a plan
$6.58K 1,644 at 4.00
0.4%
Planned (10b5-1)
8 Sep 2023
Rosenbaum David P. Chief Development Officer
Sold on a plan
$13.18K 2,897 at 4.55
0.8%
Planned (10b5-1)
21 Aug 2023
RAAB MICHAEL President & CEO
Sold at will
$40.56K 11,419 at 3.55
1.3%
Not planned
21 Aug 2023
Rodriguez Susan Chief Commercial Officer
Sold at will
$16.81K 4,733 at 3.55
1.3%
Not planned
21 Aug 2023
Renz Justin A Chief Financial Officer
Sold at will
$10.24K 2,884 at 3.55
0.9%
Not planned
21 Aug 2023
Rosenbaum David P. Chief Development Officer
Sold at will
$10.11K 2,846 at 3.55
0.8%
Not planned
21 Aug 2023
Blanks Robert See Remarks
Sold at will
$10.11K 2,846 at 3.55
1.1%
Not planned
21 Aug 2023
Williams Laura A Chief Medical Officer
Sold at will
$9.20K 2,591 at 3.55
0.9%
Not planned
21 Aug 2023
GRAMMER ELIZABETH A See Remarks
Sold at will
$8.50K 2,392 at 3.55
0.7%
Not planned
21 Aug 2023
Felsch Robert Ora See Remarks
Sold at will
$3.72K 1,048 at 3.55
0.9%
Not planned
21 Aug 2023
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$3.33K 937 at 3.55
0.8%
Not planned
27 Jun 2023
Williams Laura A Chief Medical Officer
Sold at will
$83.63K 25,000 at 3.35
7.8%
Not planned
23 Jun 2023
Blanks Robert See Remarks
Sold on a plan
$121.04K 33,333 at 3.63
11.1%
Planned (10b5-1)
23 May 2023
RAAB MICHAEL President & CEO
Sold at will
$41.49K 11,357 at 3.65
1.3%
Not planned
23 May 2023
Rodriguez Susan Chief Commercial Officer
Sold at will
$17.21K 4,711 at 3.65
1.3%
Not planned
23 May 2023
Renz Justin A Chief Financial Officer
Sold at will
$10.50K 2,873 at 3.65
0.8%
Not planned
23 May 2023
Blanks Robert See Remarks
Sold at will
$10.36K 2,835 at 3.65
1.1%
Not planned
23 May 2023
Rosenbaum David P. Chief Development Officer
Sold at will
$10.36K 2,835 at 3.65
0.8%
Not planned
23 May 2023
Williams Laura A Chief Medical Officer
Sold at will
$9.44K 2,583 at 3.65
0.8%
Not planned
23 May 2023
GRAMMER ELIZABETH A See Remarks
Sold at will
$8.71K 2,384 at 3.65
0.7%
Not planned
23 May 2023
Felsch Robert Ora See Remarks
Sold at will
$3.82K 1,046 at 3.65
0.9%
Not planned
23 May 2023
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$3.41K 934 at 3.65
0.8%
Not planned
29 Mar 2023
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$13.89K 3,000 at 4.63
2.6%
Not planned
21 Feb 2023
RAAB MICHAEL President & CEO
Sold, plan not stated
$40.36K 13,449 at 3.00
1.5%
21 Feb 2023
Rodriguez Susan Chief Commercial Officer
Sold, plan not stated
$16.76K 5,586 at 3.00
1.5%
21 Feb 2023
Renz Justin A Chief Financial Officer
Sold, plan not stated
$10.32K 3,439 at 3.00
1.0%
21 Feb 2023
Blanks Robert See Remarks
Sold, plan not stated
$10.19K 3,394 at 3.00
1.2%
21 Feb 2023
Rosenbaum David P. Chief Development Officer
Sold, plan not stated
$10.19K 3,394 at 3.00
0.9%
21 Feb 2023
Felsch Robert Ora See Remarks
Sold, plan not stated
$9.65K 3,214 at 3.00
2.7%
21 Feb 2023
Williams Laura A Chief Medical Officer
Sold, plan not stated
$9.56K 3,187 at 3.00
1.0%
21 Feb 2023
GRAMMER ELIZABETH A See Remarks
Sold, plan not stated
$8.74K 2,914 at 3.00
0.9%
21 Feb 2023
Rosenbaum David P. Chief Development Officer · indirect
Sold, plan not stated
$3.34K 1,114 at 3.00
1.0%
22 Nov 2022
RAAB MICHAEL President & CEO
Sold, plan not stated 3×
$12.12K 6,219 at 1.95
0.9%
22 Nov 2022
Rodriguez Susan Chief Commercial Officer
Sold, plan not stated 3×
$6.74K 3,456 at 1.95
1.2%
22 Nov 2022
Renz Justin A Chief Financial Officer
Sold, plan not stated 2×
$2.93K 1,504 at 1.95
0.6%
22 Nov 2022
Rosenbaum David P. Chief Development Officer
Sold, plan not stated 3×
$2.85K 1,464 at 1.95
0.5%
22 Nov 2022
Blanks Robert See Remarks
Sold, plan not stated 3×
$2.85K 1,464 at 1.95
0.7%
22 Nov 2022
GRAMMER ELIZABETH A See Remarks
Sold, plan not stated 3×
$2.42K 1,242 at 1.95
0.5%
22 Nov 2022
Williams Laura A Chief Medical Officer
Sold, plan not stated 3×
$2.42K 1,241 at 1.95
0.5%
22 Nov 2022
Rosenbaum David P. Chief Development Officer · indirect
Sold, plan not stated 3×
$943.36 484 at 1.95
0.5%
17 Nov 2022
MOTT DAVID M Director
Bought
$1.00M 567,000 at 1.76
94.5%
+95% of stake
5 Oct 2022
Blanks Robert See Remarks
Sold, plan not stated
$150.00K 100,000 at 1.50
33.8%
1 Sep 2022
Rosenbaum David P. Chief Development Officer · indirect
Sold, plan not stated
$2.76K 3,000 at 0.92
3.2%
31 Aug 2022
Felsch Robert Ora See Remarks
Bought
$1.86K 3,000 at 0.62
3.4%
First buy on file
31 Aug 2022
Rosenbaum David P. Chief Development Officer · indirect
Bought
$1.86K 3,000 at 0.62
3.4%
First buy on file
31 Aug 2022
Renz Justin A Chief Financial Officer
Bought
$1.86K 3,000 at 0.62
1.2%
First buy on file
31 Aug 2022
Williams Laura A Chief Medical Officer
Bought
$1.86K 3,000 at 0.62
1.2%
First buy on file
Showing 151–200 of 346. ← Newer Page 4 of 7 Older →